Status:
COMPLETED
Total-Body Parametric 18F-FDG PET of COVID-19
Lead Sponsor:
University of California, Davis
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective is to measure the change between COVID-19 patients and normal subjects; the secondary objective is to measure the change in COVID-19 patients between baseline and 4-month follow ...
Eligibility Criteria
Inclusion
- COVID-19 positive patients will have a previous positive COVID-19 test and radiographic findings, and/or a positive SARS-CoV-2 antibody test and be in early recovery.
- First PET/CT visit needs to be within 8 weeks of COVID-19 diagnosis.
- Ability to understand and willingness to sign an informed consent form.
- Ability to adhere to the study visit schedule and other protocol requirements.
- All persons ≥18 years of age.
Exclusion
- Pregnant or lactating women.
- Any condition that would prohibit the understanding or rendering of informed consent.
- Unable to lie supine for 1-hour imaging with PET.
- Prisoners.
- Any comorbidity that, in the opinion of the investigator, could compromise protocol objectives.
Key Trial Info
Start Date :
May 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 6 2022
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT04841707
Start Date
May 10 2021
End Date
July 6 2022
Last Update
December 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Davis
Sacramento, California, United States, 95817